Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline Journal Articles uri icon

  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All


  • AbstractThis clinical practice guideline provides recommendations for preventing acute and delayed phase chemotherapy‐induced nausea and vomiting (CINV) in pediatric patients. The recommendations are based on two systematic reviews of randomized controlled trials evaluating interventions to prevent (1) acute phase CINV and (2) delayed phase CINV. Recommendations for acute phase and delayed phase CINV prophylaxis are made for patients receiving chemotherapy of varying emetogenicity, as well as for patients not able to receive dexamethasone or a neurokinin‐1 receptor antagonist. Evidence gaps, including antiemetic safety and optimal dosing, were identified.


  • Patel, Priya
  • Robinson, Paula D
  • Cohen, Marie
  • Devine, Katie
  • Gibson, Paul
  • Holdsworth, Mark T
  • Neumann, Eloise
  • Orsey, Andrea
  • Phillips, Robert
  • Spinelli, Daniela
  • Thackray, Jennifer
  • van de Wetering, Marianne
  • Woods, Deborah
  • Cabral, Sandra
  • Sung, Lillian
  • Dupuis, L Lee

publication date

  • December 2022